These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28612162)

  • 1. LI-RADS and transplantation for hepatocellular carcinoma.
    Tang A; Fowler KJ; Chernyak V; Chapman WC; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):193-202. PubMed ID: 28612162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
    AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
    [No Abstract]   [Full Text] [Related]  

  • 3. LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study.
    Piñero F; Thompson MA; Diaz Telli F; Trentacoste J; Padín C; Mendizabal M; Colaci C; Gonzalez Campaña A; Pages J; Montal S; Barreiro M; Fauda M; Podestá G; Perotti JP; Silva M
    Ann Hepatol; 2020; 19(6):662-667. PubMed ID: 32683095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
    Kambadakone AR; Fung A; Gupta RT; Hope TA; Fowler KJ; Lyshchik A; Ganesan K; Yaghmai V; Guimaraes AR; Sahani DV; Miller FH
    Abdom Radiol (NY); 2018 Jan; 43(1):56-74. PubMed ID: 28940042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
    Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK
    Abdom Radiol (NY); 2018 Jan; 43(1):218-230. PubMed ID: 28780679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Imaging Reporting and Data System Version 2018: Impact on Categorization and Hepatocellular Carcinoma Staging.
    Chernyak V; Flusberg M; Berman J; Fruitman KC; Kobi M; Fowler KJ; Sirlin CB
    Liver Transpl; 2019 Oct; 25(10):1488-1502. PubMed ID: 31344753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
    Santillan C; Fowler K; Kono Y; Chernyak V
    Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
    Bashir MR; Huang R; Mayes N; Marin D; Berg CL; Nelson RC; Jaffe TA
    J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LI-RADS
    Chernyak V; Santillan CS; Papadatos D; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):111-126. PubMed ID: 28695233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured Reporting of Multiphasic CT for Hepatocellular Carcinoma: Effect on Staging and Suitability for Transplant.
    Poullos PD; Tseng JJ; Melcher ML; Concepcion W; Loening AM; Rosenberg J; Willmann JK
    AJR Am J Roentgenol; 2018 Apr; 210(4):766-774. PubMed ID: 29470153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
    Ehman EC; Behr SC; Umetsu SE; Fidelman N; Yeh BM; Ferrell LD; Hope TA
    Abdom Radiol (NY); 2016 May; 41(5):963-9. PubMed ID: 27193793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LI-RADS categories: concepts, definitions, and criteria.
    Santillan C; Chernyak V; Sirlin C
    Abdom Radiol (NY); 2018 Jan; 43(1):101-110. PubMed ID: 29038857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LI-RADS and transplantation: challenges and controversies.
    Cunha GM; Tamayo-Murillo DE; Fowler KJ
    Abdom Radiol (NY); 2021 Jan; 46(1):29-42. PubMed ID: 31696268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of discordant findings between hepatic angiography and cross-sectional imaging in transplant candidates with hepatocellular carcinoma.
    Young K; Fidelman N; Yao FY; Hills NK; Kohi MP; Kolli KP; Taylor AG; Kerlan RK
    Liver Transpl; 2015 Apr; 21(4):454-67. PubMed ID: 25678220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
    van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
    Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplant benefit for patients with hepatocellular carcinoma.
    Vitale A; Volk M; Cillo U
    World J Gastroenterol; 2013 Dec; 19(48):9183-8. PubMed ID: 24409046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.